R1	Has_temporal Arg1:T3 Arg2:T4	
*	OR T2 T1
R2	AND Arg1:T6 Arg2:T7	
R3	Has_qualifier Arg1:T8 Arg2:T9	
R4	Has_qualifier Arg1:T8 Arg2:T10	
R5	Has_value Arg1:T11 Arg2:T12	
*	OR T13 T14
*	OR T15 T16 T17 T18 T19
R6	Subsumes Arg1:T13 Arg2:T15	
R7	Has_qualifier Arg1:T23 Arg2:T24	
R8	Has_qualifier Arg1:T26 Arg2:T27	
R9	Has_qualifier Arg1:T29 Arg2:T30	
R10	Has_qualifier Arg1:T32 Arg2:T33	
T1	Condition 31 51	coagulation disorder
T2	Condition 22 30;43 51	clotting disorder
T3	Condition 64 70	cancer
T4	Temporal 83 92	last year
T5	Drug 119 135	anti-coagulation
T6	Condition 148 164	hypersensitivity
T7	Drug 177 185	apixaban
T8	Condition 217 225	bleeding
T9	Qualifier 205 216	significant
T10	Qualifier 187 193	Active
T11	Measurement 227 237	Creatinine
T12	Value 238 249	> 1.5 mg/dL
T13	Drug 296 311	anticoagulation
T14	Drug 315 341	blood thinning medications
T15	Drug 353 360	heparin
T16	Drug 362 391	low molecular weight heparins
T17	Drug 393 399	Plavix
T18	Drug 401 408	aspirin
T19	Drug 410 416	NSAIDS
T22	Drug 427 441;479 488	P-glycoprotein inhibitor
T23	Drug 453 468;475 488	cytochrome P450 3A4 inhibitor
T24	Qualifier 446 452	strong
T25	Drug 499 513;535 544	P-glycoprotein inhibitor
T26	Drug 527 544	CYP 3A4 inhibitor
T27	Qualifier 518 526	moderate
T28	Drug 555 577	P-glycoprotein inducer
T29	Drug 589 604	CYP 3A4 inducer
T30	Qualifier 582 588	strong
T31	Drug 606 632	Inducers of p-glycoprotein
T32	Drug 641 660	inducers of CYP 3A4
T33	Qualifier 634 640	Strong
